Featured Research

from universities, journals, and other organizations

Specific enzyme inhibitor may help control lung inflammation

Date:
January 4, 2011
Source:
Federation of American Societies for Experimental Biology
Summary:
All of us may be able to breathe a little easier now that scientists have found a new therapeutic target for controlling dangerous inflammation in the lungs. New research suggests that blocking the activation of an enzyme called delta-protein kinase C could protect the lungs from neutrophil-mediated damage, which can result in out of control inflammation.

All of us may be able to breathe a little easier now that scientists from Pennsylvania have found a new therapeutic target for controlling dangerous inflammation in the lungs. A new research report in the January 2011 issue of the Journal of Leukocyte Biology suggests that blocking the activation of an enzyme called delta-protein kinase C (delta-PKC) could protect the lungs from neutrophil-mediated damage, which can result in out of control inflammation. In an animal model of acute respiratory distress syndrome (ARDS), inhibiting delta-PKC in the lungs showed dramatically reduced inflammation, thereby protecting the lungs from further damage.

Related Articles


"ARDS is a major public health problem and one of the leading causes of death in intensive care units. It is characterized by excessive pulmonary inflammation and neutrophil infiltrations of the lung," said Laurie E. Kilpatrick, Ph.D., co author of the study from the Center for Inflammation, Translational and Clinical Lung Research and Department of Physiology at Temple University School of Medicine in Philadelphia. "While no specific pharmacologic therapeutics are available to treat this disease, control of delta-PKC activity may offer a unique therapeutic target for the treatment of ARDS and prevent the significant morbidity and mortality associated with sepsis and trauma."

To make this discovery, Kilpatrick and colleagues used a rat model of severe inflammation or sepsis that produces lung injury. The animals were divided into two groups; one group received the inhibitor directly into the lungs and the other group received a placebo. After 24 hours, the placebo group showed signs of lung injury and illness, lung tissue damage and breathing problems. In contrast, the group that received the delta-PKC inhibitor had markedly reduced evidence of lung injury and distress. These results suggest that delta-PKC is an important regulator of inflammation in the lung and that targeted inhibition of this enzyme may protect the lungs from the damage associated with severe infection.

"ARDS and acute lung inflammation can be very dangerous for patients, can progress rapidly and can be difficult for doctors to treat," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "This study is important not only because it offers some potential clues about how to treat and control acute lung inflammation, but also because it points to the mechanistic pathways involved that might be targeted to prevent this dangerous inflammatory situation in the first place."

According to the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health, ARDS leads to low oxygen levels in the blood and can be life threatening. ARDS usually occurs in very ill people who have another disease or who have major injuries. Most people are already in the hospital when they develop ARDS. Some people who survive ARDS may recover completely, while other may have lasting damage to their lungs and other related health problems.


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. L. E. Kilpatrick, S. W. Standage, H. Li, N. R. Raj, H. M. Korchak, M. R. Wolfson, C. S. Deutschman. Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC). Journal of Leukocyte Biology, 2010; DOI: 10.1189/jlb.0510281

Cite This Page:

Federation of American Societies for Experimental Biology. "Specific enzyme inhibitor may help control lung inflammation." ScienceDaily. ScienceDaily, 4 January 2011. <www.sciencedaily.com/releases/2011/01/110104134039.htm>.
Federation of American Societies for Experimental Biology. (2011, January 4). Specific enzyme inhibitor may help control lung inflammation. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2011/01/110104134039.htm
Federation of American Societies for Experimental Biology. "Specific enzyme inhibitor may help control lung inflammation." ScienceDaily. www.sciencedaily.com/releases/2011/01/110104134039.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins